Julie Marie Vose, MD


  • 40000 Citations
  • 90 h-Index
1984 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Julie Marie Vose is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Autologous Transplantation Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1984 2021


Cerny, R., Issenberg, P., Bresnick, E., Kuszynski, C. A., Christman, J., Lynch, J. C., Tempero, M., Nagel, D., Smith, D. L., Kuszynski, C. A., Pour, P., Vose, J. M., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Sherman, S., Lawson, T. A., Johnson, D. R., Kessinger, M. A., Cowan, K. H., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Volsky, D., Conrad, R., Nagel, D., Rhode, S., Ruddon, R., Ramspott, E., Pour, P., Gmeiner, W., Lewis, R. E., Borgstahl, G. E., Caplan, S. H., Band, H., Ganti, A. K. P., Meza, J. L., Black, J. D., Guda, B., Wang, J., Semerad, C. L. & Wang, G.

National Institutes of Health


Project: Research project

Tissue and Organ Procurement
Molecular Biology
Research Personnel

FLT-PET/CT for Therapy Monitoring of DLBCL

Fayad, L., Quon, A. & Vose, J. M.

National Institutes of Health


Project: Research project

Lymphoma, Large B-Cell, Diffuse
Positron-Emission Tomography
Positron Emission Tomography Computed Tomography
Bone Marrow
Stem Cell Transplantation
Clinical Trials
Peripheral Blood Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Bone Marrow

Research Output 1987 2020

Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas

Zhang, X., Bi, C., Lu, T., Zhang, W., Yue, T., Wang, C., Tian, T., Zhang, X., Huang, Y., Lunning, M., Hao, X., Brown, L. E., Devine, W. G., Vose, J., Porco, J. A. & Fu, K., Jan 1 2020, In : Leukemia. 34, 1, p. 138-150 13 p.

Research output: Contribution to journalArticle

Oncogene Proteins
Aurora Kinase A
Disease Resistance

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients

Sibon, D., Nguyen, D. P., Schmitz, N., Suzuki, R., Feldman, A. L., Gressin, R., Lamant, L., Weisenburger, D. D., Rosenwald, A., Nakamura, S., Ziepert, M., Maurer, M. J., Bast, M., Armitage, J. O., Vose, J. M., Tilly, H., Jais, J. P. & Savage, K. J., Dec 1 2019, In : Haematologica. 104, 12, p. e562-e565

Research output: Contribution to journalLetter

Open Access
1 Citation (Scopus)

A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib

Chaturvedi, N. K., Hatch, N. D., Sutton, G. L., Kling, M., Vose, J. M. & Joshi, S. S., Apr 16 2019, In : Leukemia and Lymphoma. 60, 5, p. 1214-1223 10 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Histone Deacetylases
Cell Line
Cyclin D1

Assessing an ASCO decision aid for improving the accuracy and attribution of serious adverse event reporting from investigators to sponsors

Mileham, K. F., Schenkel, C., Chuk, M. K., Buchmeier, A., Perez, R. P., Hurley, P., Levit, L. A., Garrett-Mayer, E., Davis, C., Bruinooge, S. S. & Vose, J., Jan 1 2019, In : Journal of oncology practice. 15, 12, p. e1050-e1065

Research output: Contribution to journalArticle

Decision Support Techniques
Research Personnel
Investigational Drugs
Odds Ratio

Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma

Gopalsamy, S. N., Rosenthal, K. M., Ayers, A. A., Goy, A., Leonard, J. P., Vose, J. M., Obholz, K. L., Armitage, J. O. & Flowers, C. R., Jul 29 2019, In : Leukemia and Lymphoma. 60, 9, p. 2255-2263 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Expert Testimony
Standard of Care